Neurizon Therapeutics Gets European Orphan Drug Designation for NUZ-001

Highlights: Notice of positive opinion received from the European Medicines Agency for Orphan Medicinal Product Designation for NUZ-001 in Amyotrophic Lateral Sclerosis Orphan Designation offers 10 years of market exclusivity in Europe upon product approval, along with additional regulatory and commercial benefits Positions Neurizon to advance the development of NUZ-001 for patients…

Canaan and HIVE Partner on Avalon A1566 Miner Deal

Continues North American Expansion with Order from Long-term Customer SINGAPORE, Nov. 11, 2024 — Canaan Inc. (NASDAQ: CAN) (“Canaan” or the “Company”), a leading high-performance computing solutions provider, today announced that Canaan Creative Global Pte. Ltd. (“CCG”), a wholly owned Singapore subsidiary of the Company, has entered into a purchase…

Shealth.AI Secures Investment from XVC Tech, Transforming Healthcare Diagnostics with a Focus on Data Privacy

EQS Newswire / 11/11/2024 / 17:00 UTC+8 Dubai, UAE - November 11, 2024 - (SeaPRwire) - Shealth.AI (http://shealth.ai) is proud to announce they have secured investment from XVC Tech. Shealth.AI harnesses advanced Artificial Intelligence (AI) to revolutionize diagnostics, gaining early traction among hospitals and diagnostic center. This milestone marks XVC…